BIOSANTE PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-11-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: BIOSANTE PHARMACEUTICALS INC, 10-Q, 2000-11-13
Next: EMPIRE FEDERAL BANCORP INC, 10QSB, 2000-11-13



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SEPTEMBER
30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           3,235
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 3,321
<PP&E>                                             661
<DEPRECIATION>                                     257
<TOTAL-ASSETS>                                   3,725
<CURRENT-LIABILITIES>                              697
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        17,741
<OTHER-SE>                                    (14,713)
<TOTAL-LIABILITY-AND-EQUITY>                     3,725
<SALES>                                              0
<TOTAL-REVENUES>                                   182
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 2,693
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (2,511)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (2,511)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,511)
<EPS-BASIC>                                      (.04)
<EPS-DILUTED>                                    (.04)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission